Michael Barbella, Managing Editor05.23.23
Heart Rhythm 2023's second day featured discussions and presentations on atrial fibrillation, ablation biophysics, post-EP procedural workflows, artificial intelligence, CCM therapy, and efficient PVI, as well as numerous continuing education courses and late-breaking scientific sessions.
Boston Scientific sponsored a discussion on the future of LAAC (left atrial appendage closure) devices, providing a glimpse into potential forthcoming innovation in left atrial appendage closure technology. The healing mechanism behind a new, coated, device was discussed, as well as its potential impact to patient care. The talk also focused on practical tips regarding the implantation and use of future devices and conclude with a roundtable discussion.
The 44th annual Heart Rhythm Society (HRS) meeting, held in New Orleans, brought together more than 7,700 clinicians, scientists, researchers, and innovators from in the field of cardiac pacing and electrophysiology. With a focus on science and innovation, this year's meeting included a 24% increase in regular scientific abstract submissions since 2022 and a greater number of late-breaking abstract submissions than in each of the last six years for its Late-Breaking Clinical Trial and Science sessions.
Heart Rhythm 2023 offered more than 200 sessions led by over 1,500 expert faculty and abstract presenters from around the world. An online-only option was available for those unable to attend the event live.
The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients and is the primary information resource on heart rhythm disorders. Incorporated in 1979 and based in Washington, D.C., it has a membership of more than 8,000 heart rhythm professionals from 94 countries.
Boston Scientific sponsored a discussion on the future of LAAC (left atrial appendage closure) devices, providing a glimpse into potential forthcoming innovation in left atrial appendage closure technology. The healing mechanism behind a new, coated, device was discussed, as well as its potential impact to patient care. The talk also focused on practical tips regarding the implantation and use of future devices and conclude with a roundtable discussion.
The 44th annual Heart Rhythm Society (HRS) meeting, held in New Orleans, brought together more than 7,700 clinicians, scientists, researchers, and innovators from in the field of cardiac pacing and electrophysiology. With a focus on science and innovation, this year's meeting included a 24% increase in regular scientific abstract submissions since 2022 and a greater number of late-breaking abstract submissions than in each of the last six years for its Late-Breaking Clinical Trial and Science sessions.
Heart Rhythm 2023 offered more than 200 sessions led by over 1,500 expert faculty and abstract presenters from around the world. An online-only option was available for those unable to attend the event live.
The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients and is the primary information resource on heart rhythm disorders. Incorporated in 1979 and based in Washington, D.C., it has a membership of more than 8,000 heart rhythm professionals from 94 countries.
